Anne Vincent‐Salomon

Research interests

Publications

• Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

  JAMA · 2024 · 10.1001/jama.2024.3056

• Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer

  Cell · 2022 · https://doi.org/10.1016/j.cell.2022.02.021

• Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

  Cancer Research · 2022 · 10.1158/0008-5472.can-22-1427

• The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

  The Journal of Pathology · 2020 · https://doi.org/10.1002/path.5406

• Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

  npj Breast Cancer · 2020 · https://doi.org/10.1038/s41523-020-0156-0

• The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

  The Journal of Pathology · 2020 · https://doi.org/10.1002/path.5406

• Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer

  Cancer Discovery · 2020 · 10.1158/2159-8290.cd-19-1384

• Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms

  Nature Communications · 2020 · 10.1038/s41467-019-14134-w

• Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells

  Immunity · 2020 · 10.1016/j.immuni.2020.06.002

• Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

  Annals of Oncology · 2019 · https://doi.org/10.1093/annonc/mdz395

• miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers

  Nature Communications · 2018 · 10.1038/s41467-018-03348-z

• Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

  Cancer Cell · 2018 · https://doi.org/10.1016/j.ccell.2018.01.011

• PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers

  Cell Metabolism · 2018 · 10.1016/j.cmet.2018.09.002

• Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy448

• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

  Nature Medicine · 2017 · https://doi.org/10.1038/nm.4292

• A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

  Nature Communications · 2016 · https://doi.org/10.1038/ncomms12222

• Landscape of somatic mutations in 560 breast cancer whole-genome sequences

  Nature · 2016 · https://doi.org/10.1038/nature17676

• Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

  The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)00188-6

• Phyllodes tumours of the breast: a consensus review

  Histopathology · 2015 · https://doi.org/10.1111/his.12876

• Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

  Science · 2014 · https://doi.org/10.1126/science.1251343

• Signatures of mutational processes in human cancer

  Nature · 2013 · https://doi.org/10.1038/nature12477

• Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry

  The American Journal of Surgical Pathology · 2013 · https://doi.org/10.1097/pas.0b013e3182918a2b

• Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation

  Cancer Research · 2012 · https://doi.org/10.1158/0008-5472.can-12-1470

• The landscape of cancer genes and mutational processes in breast cancer

  Nature · 2012 · https://doi.org/10.1038/nature11017

• Oxidative stress promotes myofibroblast differentiation and tumour spreading

  EMBO Molecular Medicine · 2010 · https://doi.org/10.1002/emmm.201000073

• Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

  Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-08-0030

• A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

  Clinical Cancer Research · 2007 · https://doi.org/10.1158/1078-0432.ccr-07-0078

• A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050434

• Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

  Clinical Cancer Research · 2004 · https://doi.org/10.1158/1078-0432.ccr-0102-03

• Columnar Cell Lesions of the Breast

  Advances in Anatomic Pathology · 2003 · 10.1097/00125480-200305000-00001

• Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes

  Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.20.5.1304

Current projects

No projects listed.